Clinical Trials Browser

Phase 2 × Uveal Melanoma × quisinostat × Clear all

NCT06932757 2025-06-03

Adjuvant Quisinostat in High-Risk Uveal Melanoma

Phase 2 Recruiting

Uveal Melanoma